- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: BMS-936557 | MDX-1100
Compound class: Antibody
Comment: Eldelumab (BMS-936557 and formerly MDX-1100) is a a fully human monoclonal antibody targeting the chemokine CXCL10 (a.k.a. interferon-γ-inducible protein-10 or IP-10) . It is being investigated for its anti-inflammatory action in autoimmune conditions.
BLAST peptide sequence analysis reveals exact matches with heavy and light chain variable regions claimed in patent US8258266, and identify eldelumab as clone 6A5 .
|Eldelumab does not bind other identified CXCR3 ligands CXCL9 (a.k.a. MIG) and CXCL11 (a.k.a. ITAC) .|
|Selectivity at ligand targets|
|Key to terms and symbols||Click column headers to sort|